Pfizer (PFE) Revenue — Quarter Ended Oct 1, 2023
Pfizer's revenue for the quarter increased compared to the prior quarter but fell sharply versus the same period last year. The sequential growth marked a reversal from the prior declines, while the year-over-year drop remained substantial.
Key takeaway
Quarter ended Oct 1, 2023 · FY2023 Q3
Pfizer's revenue for the quarter increased compared to the prior quarter but fell sharply versus the same period last year. The sequential growth marked a reversal from the prior declines, while the year-over-year drop remained substantial.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$13.5B
Revenue reported for this quarter.
Quarter-over-quarter
+3.7%
Change from the immediately preceding quarter.
Year-over-year
-40.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$70.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $25.1B | +55.3% |
| Apr 2, 2023 | $18.5B | -28.0% |
| Jul 2, 2023 | $13B | -53.1% |
| Oct 1, 2023 | $13.5B | -40.4% |
Revenue performance
Revenue for the quarter showed a moderate sequential increase from the prior quarter, indicating a slight recovery from earlier declines.
Quarterly comparison
Compared to the prior quarter, revenue improved, but it was down substantially from the same quarter a year ago, highlighting a significant year-over-year contraction.
What to watch
Ongoing business development activities, including proposed acquisitions, could affect future revenue trends.